MedPath

VATS Evacuation Compared to Reinsertion of Thoracostomy Tube in Persistent Traumatic Haemothorax

Not Applicable
Conditions
Hemothorax; Traumatic
Interventions
Device: VATS evacuation
Device: thoracostomy tube
Registration Number
NCT03501524
Lead Sponsor
Assiut University
Brief Summary

This is prospective, randomized study comparing VATS (video- Assisted Thoracoscopy) to reinsertion of a thoracostomy tube in patients with persistent traumatic haemothorax. The incidence varies and can be as high as 20%, but in most studies is found to be 1-4% after initial tube thoracostomy for chest trauma. The most accepted complication of retained hemothorax is empyema.Retained hemothorax treatment started by physiotherapy and early withdrawal of tube thoracostomy which lead to more complications as empyema, fibro thorax/entrapped lung, flail chest and diaphragmatic hernia. Early VATS is an alternative treatment for retained hemothorax with evidence that it is a superior intervention when compared to a second tube thoracostomy.

Detailed Description

Traumatic injuries are a significant cause of morbidity and mortality in our society.At Assiut university hospitals, chest injuries (17.7%) considered as second cause of mortality after head injuries (34.6%) of registered deaths by cause of injury at trauma unit, Assiut university hospitals in a study conducted between,2002-2009. In United States, thoracic injuries are the primary factor in approximately 35% of these deaths, one -third of which occur immediately following the injury, and are contributing in nearly 75% of trauma -related deaths. Up to 15% of patients who sustain thoracic trauma undergo emergent thoracotomy for resuscitation, massive hemothorax, cardiac tamponade, large thoracic wounds, major thoracic vascular injuries, tracheobronchial injuries, or evidence of esophageal injury. The remaining 85-90% of patients who reach the emergency department does not require emergent thoracotomy are initially managed with tube thoracostomy, pain control, pulmonary toilet, and observation .Patients failing this management ultimately require elective thoracotomy for further evaluation and treatment(clotted hemothorax, empyema and diaphragmatic hernia. The current role of VATS in trauma includes evaluation and control of continued chest tube bleeding, early evacuation of retained hemothorax, evacuation and decortication of posttraumatic empyemas, evaluation and limited treatment of suspected diaphragm injuries, evaluation and treatment of persistent air leaks, and evaluation of mediastinal injuries.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2
Inclusion Criteria

We include for the study all patients admitted to Assiut university hospitals during the time of the study that proved persistent haemothorax that with criteria:

  1. Ages that are eligible for study are between 18years to 60 years (adult)
  2. Both genders will be included to study.
  3. Clinical and radiological diagnosis of persistent haemothorax.
  4. Thoracostomy tube blockage or failure to drain within 5-7days.
Read More
Exclusion Criteria
  1. More than one thoracostomy tube drainage in the same attempt side.
  2. Unable to consent to trial.
  3. Coexisting pathology requiring other interventions.
  4. Patients that need urgent interventions (hemodynamically unstable, empyema and flail chest).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VATS evacuationthoracostomy tubepatients selected for VATS after failure of first thoracostomy tube drainage
VATS evacuationVATS evacuationpatients selected for VATS after failure of first thoracostomy tube drainage
thoracostomy tubethoracostomy tubepatients selected for thoracostomy tube reinsertion after failure of drainage with first thoracostomy tube
thoracostomy tubeVATS evacuationpatients selected for thoracostomy tube reinsertion after failure of drainage with first thoracostomy tube
Primary Outcome Measures
NameTimeMethod
Duration of hospitalizationaverage 5-7 days

number of days spent

Secondary Outcome Measures
NameTimeMethod
number of patients developed empyemathrough one month

the study will be monitored for septic complications , specially empyema.

Trial Locations

Locations (1)

Assiut university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath